CDK13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.355600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.986200E-01
Normal-vs-Stage2
4.426000E-01
Normal-vs-Stage3
2.022600E-01
Normal-vs-Stage4
4.954400E-01
Stage1-vs-Stage2
7.290600E-01
Stage1-vs-Stage3
1.255660E-02
Stage1-vs-Stage4
8.438600E-01
Stage2-vs-Stage3
1.367960E-02
Stage2-vs-Stage4
5.895600E-01
Stage3-vs-Stage4
6.373500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.281200E-01
Normal-vs-AfricanAmerican
3.944800E-01
Normal-vs-Asian
2.150400E-01
Caucasian-vs-AfricanAmerican
4.515600E-01
Caucasian-vs-Asian
9.621200E-01
AfricanAmerican-vs-Asian
6.367600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.287200E-01
Normal-vs-Female
4.467000E-01
Male-vs-Female
6.928600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.579400E-01
Normal-vs-Age(41-60Yrs)
5.606000E-01
Normal-vs-Age(61-80Yrs)
3.870400E-01
Normal-vs-Age(81-100Yrs)
3.660200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.512400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.058400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.477800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.156710E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.129800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.516800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.583200E-01
Normal-vs-Daily Drinker
3.597000E-01
Normal-vs-Weekly Drinker
1.688780E-01
Normal-vs-Occasional Drinker
5.052800E-01
Normal-vs-Social Drinker
5.867400E-01
Non Drinker-vs-Daily Drinker
9.970400E-01
Non Drinker-vs-Weekly Drinker
5.361800E-01
Non Drinker-vs-Occasional Drinker
7.197700E-02
Non Drinker-vs-Social Drinker
1.936390E-02
Daily Drinker-vs-Weekly Drinker
5.734200E-01
Daily Drinker-vs-Occasional Drinker
9.722400E-02
Daily Drinker-vs-Social Drinker
3.116300E-02
Weekly Drinker-vs-Occasional Drinker
4.575200E-01
Weekly Drinker-vs-Social Drinker
2.310800E-01
Occasional Drinker-vs-Social Drinker
4.618800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.369400E-01
Normal-vs-Grade 2
6.837600E-01
Normal-vs-Grade 3
6.213400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.701000E-01
Grade 1-vs-Grade 3
7.742400E-01
Grade 1-vs-Grade 4
2.369400E-01
Grade 2-vs-Grade 3
1.058180E-01
Grade 2-vs-Grade 4
6.837600E-01
Grade 3-vs-Grade 4
6.213400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.485800E-01
Normal-vs-NonDiabetic
4.501800E-01
Diabetic-vs-NonDiabetic
3.595900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.828600E-01
Normal-vs-NoPancreatitis
4.253000E-01
Pancreatitis-vs-NoPancreatitis
5.545800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.125600E-01
Normal-vs-N1
4.454800E-01
N0-vs-N1
4.904800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.287400E-01
Normal-vs-TP53-NonMutant
5.658600E-01
TP53-Mutant-vs-TP53-NonMutant
6.289200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
